Es gab 50 kürzliche Insider-Transaktionen für Aligos Therapeutics, Inc. (ALGS), darunter 38 Käufe und 8 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $10.08M und die gesamten Insider-Verkäufe auf $6.13M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Blatt Lawrence, Calhoun Lesley Ann, Aneja Nikhil. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — ALGS
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-03-09 |
Blatt Lawrence |
President and CEO |
RSU-Zuteilung |
105,840 |
$7.03 |
$744.06K |
105,840 |
| 2026-03-09 |
Calhoun Lesley Ann |
See Remarks |
RSU-Zuteilung |
37,485 |
$7.03 |
$263.52K |
37,485 |
| 2026-03-09 |
Aneja Nikhil |
Principal Accounting Officer |
RSU-Zuteilung |
9,450 |
$7.03 |
$66.43K |
9,450 |
| 2026-01-29 |
Aneja Nikhil |
Principal Accounting Officer |
Unbekannt |
3,600 |
$8.68 |
$31.25K |
- |
| 2025-07-16 |
Blatt Lawrence |
President and CEO |
RSU-Zuteilung |
179,800 |
$8.68 |
$1.56M |
179,800 |
| 2025-07-16 |
Calhoun Lesley Ann |
See Remarks |
RSU-Zuteilung |
40,185 |
$8.68 |
$348.81K |
40,185 |
| 2025-07-16 |
Symons Julian A. |
See Remarks |
RSU-Zuteilung |
16,000 |
$8.68 |
$138.88K |
16,000 |
| 2025-06-25 |
Scopa James Paul |
Director |
RSU-Zuteilung |
5,860 |
$7.63 |
$44.71K |
5,860 |
| 2025-06-25 |
Preston Heather |
Director |
RSU-Zuteilung |
5,860 |
$7.63 |
$44.71K |
5,860 |
| 2025-06-25 |
Martell Bridget A |
Director |
RSU-Zuteilung |
5,860 |
$7.63 |
$44.71K |
5,860 |
| 2025-06-25 |
Nuechterlein Carole |
Director |
RSU-Zuteilung |
5,860 |
$7.63 |
$44.71K |
5,860 |
| 2025-06-25 |
Hirth Peter |
Director |
RSU-Zuteilung |
5,860 |
$7.63 |
$44.71K |
5,860 |
| 2025-06-25 |
Chavez Margarita |
Director |
RSU-Zuteilung |
5,860 |
$7.63 |
$44.71K |
5,860 |
| 2025-02-28 |
Blatt Lawrence |
President and CEO |
RSU-Zuteilung |
140,103 |
$16.87 |
$2.36M |
140,103 |
| 2025-02-28 |
Calhoun Lesley Ann |
See Remarks |
RSU-Zuteilung |
47,271 |
$16.87 |
$797.46K |
47,271 |
| 2025-02-28 |
Symons Julian A. |
See Remarks |
RSU-Zuteilung |
21,693 |
$16.87 |
$365.96K |
21,693 |
| 2024-10-08 |
Achneck Hardean |
Chief Medical Officer |
RSU-Zuteilung |
75,000 |
$7.32 |
$549K |
75,000 |
| 2024-09-23 |
Achneck Hardean |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-09-04 |
Blatt Lawrence |
Chief Executive Officer |
RSU-Zuteilung |
33,920 |
$11.74 |
$398.22K |
33,920 |
| 2024-09-04 |
Calhoun Lesley Ann |
Other: See Remarks |
RSU-Zuteilung |
10,880 |
$11.74 |
$127.73K |
10,880 |
| 2024-09-04 |
Symons Julian A. |
See Remarks |
RSU-Zuteilung |
10,880 |
$11.74 |
$127.73K |
10,880 |
| 2024-08-07 |
Preston Heather |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-08-07 |
Preston Heather |
Director |
RSU-Zuteilung |
120,000 |
$0.55 |
$66K |
120,000 |
| 2024-08-07 |
Chavez Margarita |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-08-07 |
Chavez Margarita |
Director |
RSU-Zuteilung |
120,000 |
$0.55 |
$66K |
120,000 |
| 2024-06-27 |
Scopa James Paul |
Director |
RSU-Zuteilung |
60,000 |
$0.38 |
$22.8K |
60,000 |
| 2024-06-27 |
Martell Bridget A |
Director |
RSU-Zuteilung |
60,000 |
$0.38 |
$22.8K |
60,000 |
| 2024-06-27 |
Nuechterlein Carole |
Director |
RSU-Zuteilung |
60,000 |
$0.38 |
$22.8K |
60,000 |
| 2024-06-27 |
Hirth Peter |
Director |
RSU-Zuteilung |
60,000 |
$0.38 |
$22.8K |
60,000 |
| 2024-03-01 |
Blatt Lawrence |
Chief Executive Officer |
RSU-Zuteilung |
965,435 |
$1.13 |
$1.09M |
965,435 |
| 2024-03-01 |
Calhoun Lesley Ann |
Other: See Remarks |
RSU-Zuteilung |
308,940 |
$1.13 |
$349.1K |
308,940 |
| 2024-03-01 |
Symons Julian A. |
See Remarks |
RSU-Zuteilung |
72,000 |
$1.13 |
$81.36K |
72,000 |
| 2024-03-01 |
Mcclure Matthew W. |
Chief Medical Officer |
RSU-Zuteilung |
72,000 |
$1.13 |
$81.36K |
72,000 |
| 2024-02-28 |
Blatt Lawrence |
Chief Executive Officer |
RSU-Zuteilung |
57,749 |
$0.96 |
$55.44K |
57,749 |
| 2024-02-28 |
Scopa James Paul |
Director |
RSU-Zuteilung |
8,823 |
$0.96 |
$8.47K |
8,823 |
| 2024-02-28 |
Nielsen Jack |
Director |
RSU-Zuteilung |
4,411 |
$0.96 |
$4.23K |
4,411 |
| 2024-02-28 |
Martell Bridget A |
Director |
RSU-Zuteilung |
8,823 |
$0.96 |
$8.47K |
8,823 |
| 2024-02-28 |
Nuechterlein Carole |
Director |
RSU-Zuteilung |
4,411 |
$0.96 |
$4.23K |
4,411 |
| 2024-02-28 |
Calhoun Lesley Ann |
Other: See Remarks |
RSU-Zuteilung |
18,750 |
$0.96 |
$18K |
18,750 |
| 2024-02-28 |
Hirth Peter |
Director |
RSU-Zuteilung |
4,411 |
$0.96 |
$4.23K |
4,411 |
| 2024-02-28 |
Symons Julian A. |
See Remarks |
RSU-Zuteilung |
18,750 |
$0.96 |
$18K |
18,750 |
| 2024-02-28 |
Mcclure Matthew W. |
Chief Medical Officer |
RSU-Zuteilung |
16,428 |
$0.96 |
$15.77K |
16,428 |
| 2024-02-27 |
Blatt Lawrence |
Chief Executive Officer |
Aktienrückgabe |
80,850 |
$3.06 |
$247.4K |
- |
| 2024-02-27 |
Scopa James Paul |
Director |
Aktienrückgabe |
30,000 |
$29.10 |
$873K |
- |
| 2024-02-27 |
Nielsen Jack |
Director |
Aktienrückgabe |
15,000 |
$26.58 |
$398.7K |
- |
| 2024-02-27 |
Martell Bridget A |
Director |
Aktienrückgabe |
30,000 |
$16.52 |
$495.6K |
- |
| 2024-02-27 |
Nuechterlein Carole |
Director |
Aktienrückgabe |
15,000 |
$26.58 |
$398.7K |
- |
| 2024-02-27 |
Calhoun Lesley Ann |
Other: See Remarks |
Aktienrückgabe |
26,250 |
$3.06 |
$80.33K |
- |
| 2024-02-27 |
Hirth Peter |
Director |
Aktienrückgabe |
15,000 |
$26.58 |
$398.7K |
- |
| 2024-02-27 |
Symons Julian A. |
See Remarks |
Aktienrückgabe |
200,000 |
$16.18 |
$3.24M |
- |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
